Citation 36002

TAKASAKI,M: KONOSHIMA,T: FUJITANI,K: YOSHIDA,S: NISHIMURA,H: TOKUDA,H: NISHINO,H: IWASHIMA,A: KOZUKA,M:. (1990). INHIBITORS OF SKIN-TUMOR PROMOTION. VIII. INHIBITORY EFFECTS OF EUGLOBALS AND THEIR RELATED COMPOUNDS ON EPSTEIN-BARR VIRUS ACTIVATION.. 38(10)

Citation Details

Title	INHIBITORS OF SKIN-TUMOR PROMOTION. VIII. INHIBITORY EFFECTS OF EUGLOBALS AND THEIR RELATED COMPOUNDS ON EPSTEIN-BARR VIRUS ACTIVATION.
Authors	TAKASAKI,M: KONOSHIMA,T: FUJITANI,K: YOSHIDA,S: NISHIMURA,H: TOKUDA,H: NISHINO,H: IWASHIMA,A: KOZUKA,M:
Year	1990
Volume	38
Issue	10

Summary

Year: 1990

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL I-A-1	ACTIVE
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL I-A-2	ACTIVE
3	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL I-B	ACTIVE
4	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL I-C	ACTIVE
5	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL II-A	ACTIVE
6	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL II-B	ACTIVE
7	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL II-C	ACTIVE
8	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL III	ACTIVE
9	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL IV-A	ACTIVE
10	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL IV-B	ACTIVE
11	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL V	ACTIVE
12	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGLOBAL VII	ACTIVE
13	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHELLANDRENE,ALPHA:	ACTIVE
14	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SABINENE HYDRATE	ACTIVE
15	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMADENDRONE	ACTIVE
16	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLOBULOL	INACTIVE
17	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VIRIDOFLOROL	INACTIVE
18	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GRANDINOL	ACTIVE
19	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLOROGLUCINOL	ACTIVE

Citation 36002

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1